Quantum Biopharma annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Quantum Biopharma Depreciation & Amortization Growth & History (QNTM)
Quantum Biopharma's depreciation and amortization was $545,780 for fiscal 2025.
View full Quantum Biopharma company overviewQuantum Biopharma annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $545,780 | $55,209 | +11.25% |
| 2024 | 2024-12-31 | $490,571 | −$2.0M | −80.43% |
| 2023 | 2023-12-31 | $2.5M | −$2.0M | −44.76% |
| 2022 | 2022-12-31 | $4.5M | $491,892 | +12.16% |
| 2021 | 2021-12-31 | $4.0M | $145,065 | +3.72% |
| 2020 | 2020-12-31 | $3.9M | $2.0M | +100.74% |
| 2019 | 2019-12-31 | $1.9M | — | — |
Quantum Biopharma quarterly depreciation and amortization
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $128,368 | −$13,015 | −9.21% |
| Q1 2026 | 2026-03-31 | $127,436 | −$2,254 | −1.74% |
| Q4 2025 | 2025-12-31 | $129,371 | — | — |
| Q3 2025 | 2025-09-30 | $145,336 | $24,522 | +20.30% |
| Q2 2025 | 2025-06-30 | $141,383 | $4,570 | +3.34% |
| Q1 2025 | 2025-03-31 | $129,690 | $9,549 | +7.95% |
| Q3 2024 | 2024-09-30 | $120,814 | −$25,996 | −17.71% |
| Q2 2024 | 2024-06-30 | $136,813 | −$970,505 | −87.64% |
| Q1 2024 | 2024-03-31 | $120,141 | — | — |
| Q3 2023 | 2023-09-30 | $146,810 | — | — |
| Q2 2023 | 2023-06-30 | $1.1M | — | — |
Quantum Biopharma depreciation and amortization trends
Over the last five fiscal years, Quantum Biopharma's depreciation and amortization decreased from $3.9M to $545,780, a change of −$3.4M. The latest reported quarter, Q2 2026, shows $128,368.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quantum Biopharma source filings ↗